Back
Lyell Immunopharma Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
38
LYEL
Lyell Immunopharma
Last Price:
1.24
Seasonality Move:
-24.64%
Sell
45
NBY
NovaBay Pharmaceuticals
Last Price:
0.77
Seasonality Move:
-8.12%
Sell
38
Lyell Immunopharma (LYEL)
is a Sell
Is Lyell Immunopharma a Buy, Sell or Hold?
- The current Lyell Immunopharma [LYEL] share price is $1.28. The Score for LYEL is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- LYEL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.76. The Score for NBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LYEL Stock Price Chart
What is Lyell Immunopharma's stock price today?
-
The Lyell Immunopharma share price today is $1.28
The current trend is relatively stagnant and LYEL is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.
LYEL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 57.47 | Buy |
Chaikin Money Flow: | 1432987 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.01 - 1.25) | Buy |
Bollinger Bands (100): | (1.13 - 1.77) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 63.12 | Buy |
Chaikin Money Flow: | 100221 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.59 - 0.71) | Buy |
Bollinger Bands (100): | (0.3 - 1.84) | Sell |
LYEL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.02 | Buy |
20-day SMA: | 1.1 | Buy |
50-day SMA: | 1.25 | Buy |
200-day SMA: | 1.88 | Sell |
8-day EMA: | 1.08 | Buy |
20-day EMA: | 1.11 | Buy |
50-day EMA: | 1.25 | Buy |
200-day EMA: | 1.75 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.66 | Buy |
20-day SMA: | 0.64 | Buy |
50-day SMA: | 0.6 | Buy |
200-day SMA: | 2.66 | Sell |
8-day EMA: | 0.69 | Buy |
20-day EMA: | 0.66 | Buy |
50-day EMA: | 0.74 | Buy |
200-day EMA: | 6.3 | Sell |
Lyell Immunopharma Earnings Growth & LYEL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.04 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Lyell Immunopharma Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |